BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30581159)

  • 1. Chronic Neutrophilic Leukemia: Current and Future Perspectives.
    Venugopal S; Mascarenhas J
    Clin Lymphoma Myeloma Leuk; 2019 Mar; 19(3):129-134. PubMed ID: 30581159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and evolving understanding of atypical chronic myeloid leukemia.
    Schwartz LC; Mascarenhas J
    Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
    Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
    BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Management of Chronic Neutrophilic Leukemia.
    Szuber N; Tefferi A
    Curr Treat Options Oncol; 2021 Jun; 22(7):59. PubMed ID: 34097138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice.
    Tefferi A; Elliott M; Pardanani A
    Curr Opin Hematol; 2015 Mar; 22(2):171-6. PubMed ID: 25575036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic neutrophilic leukemia: a clinical perspective.
    Menezes J; Cigudosa JC
    Onco Targets Ther; 2015; 8():2383-90. PubMed ID: 26366092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy.
    Elliott MA; Tefferi A
    Curr Opin Hematol; 2014 Mar; 21(2):148-54. PubMed ID: 24335708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
    Maxson JE; Gotlib J; Pollyea DA; Fleischman AG; Agarwal A; Eide CA; Bottomly D; Wilmot B; McWeeney SK; Tognon CE; Pond JB; Collins RH; Goueli B; Oh ST; Deininger MW; Chang BH; Loriaux MM; Druker BJ; Tyner JW
    N Engl J Med; 2013 May; 368(19):1781-90. PubMed ID: 23656643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Tyner JW; Gotlib J
    Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
    Carratt SA; Brewer D; Maxson JE; Druker BJ; Braun TP
    Biomark Res; 2021 Jan; 9(1):8. PubMed ID: 33516272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
    Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Gotlib J; Deininger MMN; Oh ST; Cortes JE; Collins RH; Winton EF; Parker DR; Lee H; Reister A; Schultz ; Savage S; Stevens ; Brockett C; Subbiah N; Press RD; Raess PW; Cascio M; Dunlap J; Chen Y; Degnin C; Maxson JE; Tognon CE; Macey T; Druker BJ; Tyner JW
    J Clin Oncol; 2020 Apr; 38(10):1006-1018. PubMed ID: 31880950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics of chronic neutrophilic leukemia.
    Maxson JE; Tyner JW
    Blood; 2017 Feb; 129(6):715-722. PubMed ID: 28028025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2016 Mar; 91(3):341-9. PubMed ID: 26700908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia.
    Drexler HG; Nagel S; Quentmeier H
    Curr Oncol; 2021 May; 28(3):1790-1794. PubMed ID: 34068566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic neutrophilic leukemia: new science and new diagnostic criteria.
    Szuber N; Tefferi A
    Blood Cancer J; 2018 Feb; 8(2):19. PubMed ID: 29440636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y; Qiao C; Chen Y; Zhang SJ
    Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management.
    Thomopoulos TP; Symeonidis A; Kourakli A; Papageorgiou SG; Pappa V
    Front Oncol; 2022; 12():891961. PubMed ID: 35494007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2014 Jun; 89(6):651-8. PubMed ID: 24845374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.